Literature DB >> 28242802

Uncommon mutation in mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS).

Jasna David1, Julie Omolola Okiro2, Kevin Murphy1, Marwa Elamin1.   

Abstract

A 26-year-old man presented to the emergency department with new-onset generalised tonic-clonic seizures. His clinical picture suggested either autoimmune or infectious encephalitis while his brain imaging raised the possibility of a stroke. A detailed developmental and childhood medical history added suspicion of a mitochondrial defect to the differential. After several molecular genetic analyses, an uncommon mitochondrial mutation was confirmed, unequivocally consistent with mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS) syndrome. 2017 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28242802      PMCID: PMC5337635          DOI: 10.1136/bcr-2016-218133

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  22 in total

1.  Low mutant load of mitochondrial DNA G13513A mutation can cause Leigh's disease.

Authors:  Denise M Kirby; Avihu Boneh; C W Chow; Akira Ohtake; Michael T Ryan; Dominic Thyagarajan; David R Thorburn
Journal:  Ann Neurol       Date:  2003-10       Impact factor: 10.422

2.  Leigh syndrome caused by mitochondrial DNA G13513A mutation: frequency and clinical features in Japan.

Authors:  Akira Sudo; Shiho Honzawa; Ikuya Nonaka; Yu-Ichi Goto
Journal:  J Hum Genet       Date:  2004-01-17       Impact factor: 3.172

3.  The mitochondrial DNA G13513A MELAS mutation in the NADH dehydrogenase 5 gene is a frequent cause of Leigh-like syndrome with isolated complex I deficiency.

Authors:  M Chol; S Lebon; P Bénit; D Chretien; P de Lonlay; A Goldenberg; S Odent; L Hertz-Pannier; C Vincent-Delorme; V Cormier-Daire; P Rustin; A Rötig; A Munnich
Journal:  J Med Genet       Date:  2003-03       Impact factor: 6.318

4.  The mitochondrial 13513G > A mutation is most frequent in Leigh syndrome combined with reduced complex I activity, optic atrophy and/or Wolff-Parkinson-White.

Authors:  E Mariken Ruiter; Marloes H Siers; Christa van den Elzen; Baziel G van Engelen; Jan A M Smeitink; Richard J Rodenburg; Frans A Hol
Journal:  Eur J Hum Genet       Date:  2006-11-15       Impact factor: 4.246

Review 5.  Mutation of mitochondrial DNA G13513A presenting with Leigh syndrome, Wolff-Parkinson-White syndrome and cardiomyopathy.

Authors:  Shi-Bing Wang; Wen-Chin Weng; Ni-Chung Lee; Wuh-Liang Hwu; Pi-Chuan Fan; Wang-Tso Lee
Journal:  Pediatr Neonatol       Date:  2008-08       Impact factor: 2.083

6.  The G13513A mutation in the ND5 gene of mitochondrial DNA as a common cause of MELAS or Leigh syndrome: evidence from 12 cases.

Authors:  Sara Shanske; Jorida Coku; Jiesheng Lu; Jaya Ganesh; Sindu Krishna; Kurenai Tanji; Eduardo Bonilla; Ali B Naini; Michio Hirano; Salvatore DiMauro
Journal:  Arch Neurol       Date:  2008-03

Review 7.  Melas: an original case and clinical criteria for diagnosis.

Authors:  M Hirano; E Ricci; M R Koenigsberger; R Defendini; S G Pavlakis; D C DeVivo; S DiMauro; L P Rowland
Journal:  Neuromuscul Disord       Date:  1992       Impact factor: 4.296

Review 8.  Diagnosis and therapy in neuromuscular disorders: diagnosis and new treatments in mitochondrial diseases.

Authors:  S Rahman; M G Hanna
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-09       Impact factor: 10.154

9.  Psychiatric comorbidity in 36 adults with mitochondrial cytopathies.

Authors:  Omar Fattal; Jessica Link; Kathleen Quinn; Bruce H Cohen; Kathleen Franco
Journal:  CNS Spectr       Date:  2007-06       Impact factor: 3.790

10.  Mitochondrial disease in autism spectrum disorder patients: a cohort analysis.

Authors:  Jacqueline R Weissman; Richard I Kelley; Margaret L Bauman; Bruce H Cohen; Katherine F Murray; Rebecca L Mitchell; Rebecca L Kern; Marvin R Natowicz
Journal:  PLoS One       Date:  2008-11-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.